What an AI agent reads on Irene M. Ghobrial
An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from dana-farber.org, taken from the copy the scanner kept.
12,492
characters of text without JavaScript
none
structured data for the business
1
of 3 AI crawlers turned away at the edge (ClaudeBot)
The words an agent gets
Title: Home | Ghobrial Lab at Dana-Farber Cancer Institute at Dana-Farber Cancer Institute · language en. First 1,800 of 12,492 characters:
Home | Ghobrial Lab at Dana-Farber Cancer Institute at Dana-Farber Cancer Institute Skip to main content Home Our Team Lab Team Clinical Research Team Lab Alumni Ghobrial Publications News Career Opportunities Contact Us Welcome to The Ghobrial Lab Changing the Natural History of Multiple Myeloma Through Early Detection and Interception Early Detection Risk Stratification Therapeutic Interception About the Ghobrial Lab Our mission is to transform multiple myeloma from a cancer diagnosed after symptomatic disease develops into one that can be detected early, accurately predicted, and ultimately intercepted before progression. The Ghobrial Lab studies the earliest stages of multiple myeloma and related plasma-cell disorders, from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) through symptomatic disease. Our research brings together population screening, prospective longitudinal cohorts, genomics, immunology, single-cell technologies, computational modeling, and innovative clinical trials to answer three fundamental questions: Who will develop disease? Why will they progress? Can we intervene before symptomatic cancer develops? Through large-scale studies such as PROMISE and PCROWD, we identify and longitudinally follow individuals with precursor conditions, creating an opportunity to study the evolution of cancer before and during malignant transformation. We integrate clinical biomarkers with genomic, immune, and microenvironmental changes to understand why some precursor conditions remain stable for decades while others progress rapidly. These discoveries are translated into increasingly precise approaches to risk prediction, including PANGEA, which uses changes in clinical biomarkers over time to dynamically predict a
What it can say about the business
| A business type in JSON-LD | no |
| Name | no |
| Telephone | no |
| Address | no |
| Opening hours | no |
| Menu or price list | nothing |
| Cuisine in structured data | no |
| JSON-LD blocks | 0 |
The links it would act on
No booking or ordering link found. An agent has nothing to act on.
Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.